Under construction – not a live service
Sign in
Taking people in IndiaNo phase

Studies bowel preparation and colonoscopy safety in people with heart, kidney or liver disease

Observes bowel cleansing and colonoscopy in adults with chronic heart, kidney or liver disease.

Key facts

Who runs it
Asian Institute of Gastroenterology, India
Where
Hyderabad, IndiaSee the site
Trial code
Registry title
Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD
Status
Recruiting
People taking part
74 people, planned
Started
10 Aug 2024
Planned end
30 May 2025
Type of study
Observational
Treatments tested
  • Colonoscopy
Record updated
13 March 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with long-term heart, kidney or liver disease who are planned for a colonoscopy. It studies how safe and well tolerated the bowel preparation is.

Age
Adults over 18 years, up to 75 years
Sex
All sexes can join
Disease stage
Diagnosed chronic heart disease, chronic kidney disease or chronic liver failure, planned for a colonoscopy that is not an emergency

Main reasons for not taking part

  • Current or past bowel blockage or bowel surgery that removed part of the bowel
  • Known allergy to PEG
  • Emergency colonoscopy
  • Pregnant or breastfeeding women
  • Paralytic ileus or bowel perforation

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Adult >18 years
  • Diagnosed cases of chronic heart disease, chronic kidney disease or chronic liver failure planned for elective colonoscopy

Who cannot take part

  • Current or past history of bowel obstruction or resection
  • Known allergies to PEG
  • Paralytic ileus / Bowel perforation
  • Age < 18 years
  • Emergency colonoscopies
  • Pregnant or lactating women
  • Inability to protect airway

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in India

  • Asian Institute of Gastroenterology/AIG HospitalsHyderabad, IndiaContact: Dr Mohan Ramchandani, MBBS MD DMTaking people

About the trial

What the trial wants to find out

Consecutive eligible patients will be enrolled and written informed consent will be obtained from all participants. Routine blood investigations will be sent. Patients with chronic heart failure will be classified based on ejection fraction into 2 groups (EF </> 40%), patients with chronic kidney disease will be classified based on KDIGO classification system into grade I-V. Patients with chronic liver disease will be classified according to the child pugh scoring system into three groups (Child A, B and C). All patients will be undergo bowel preparation under supervision. The patients will be given 10 mg of bisacodyl, the night before colonoscopy. A PEG sachet (137.15 g) containing polyethylene glycol (118 g), sodium chloride (2.93 g), potassium chloride (1.484 g), sodium bicarbonate (3.370 g), and anhydrous sodium sulfate (11.36 g) will be constituted into 2 L solution and used for bowel preparation.

Read full original descriptionShow less

Patients will receive 1 L of PEG solution between 10 PM and 11 PM the day before and 1 L of PEG solution between 6 AM and 7 AM on the day of colonoscopy. Clear liquids will be allowed after the completion of the last bowel preparation until the start of the procedure. Liquid diet includes soups, fruit juices, rice kanji, or porridge in liquid consistency, and clear liquids such as coconut water and lemon juice.

After the adequacy of bowel preparation is deemed fit, the patients will be taken for colonoscopic examination. A single blinded outcome assessment will be done by the colonoscopist/endoscopist performing the procedure (adequacy of bowel preparation) and the endoscopy nurse (tolerability and compliance).

Colonoscopy will be performed using standard video colonoscopes (Olympus, Tokyo, Japan) between 11:00 AM and 1:00 PM without sedation. The colonoscopist / endoscopist will assess the adequacy of bowel preparation using the Boston Bowel Preparation Scale (BBPS). Excellent, good and poor bowel preparations will be defined by BBPS score of 9, 6 - 9 and < 6, respectively. (12-14) Blood sampling will be done before bowel preparation and after colonoscopy in all patients for measurement of baseline parameters, renal function status (Serum creatinine, serum urea), serum electrolytess (serum sodium, serum potassium, serum phosphate and serum calcium) and haematocrit.

Assessment of safety and tolerability will be performed using clinical examination and symptom questionnaire. Cardiovascular and gastrointestinal (GI) symptoms will be recorded. Cardiovascular symptoms such as dyspnea, palpitations, chest pain, will be recorded and scored using the NYHA classification system for symptom severity. Clinical examination will be carried out post-bowel preparation and post-procedure to assess for signs of fluid overload, i.e. auscultation for crepitations and measurement of JVP. GI symptoms such as nausea, abdominal pain, vomiting, dizziness, bloating, and headache will be recorded and scored on a 4-point scale: 1 = none, 2 = mild, 3 = moderate, and 4 = severe. The compliance of bowel preparation will be defined as "poor" for patients who consume less than 75% of the PEG preparation.

Treatments tested

  • Colonoscopy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With Chronic Heart Disease, Chronic Kidney Disease and Chronic Liver Disease
Plain-language title
Studies bowel preparation and colonoscopy safety in people with heart, kidney or liver diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06874036, who can take part
Record updated
13 March 2025